Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +7.32% | -13.51% | +74.26% |
04-29 | Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children | MT |
04-29 | Transcript : Aquestive Therapeutics, Inc. - Special Call |
Evolution of the average Target Price on Aquestive Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aquestive Therapeutics, Inc.
Piper Sandler | |
Raymond James | |
HC Wainwright | |
JMP Securities | |
Wedbush | |
Alliance Global Partners | |
Oppenheimer | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- AQST Stock
- Consensus Aquestive Therapeutics, Inc.